相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase 2 study of ibrutinib in classic and variant hairy cell leukemia
Kerry A. Rogers et al.
BLOOD (2021)
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
Yair Herishanu et al.
BLOOD (2021)
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
Michael Grever et al.
LEUKEMIA (2021)
Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia
Dai Chihara et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up
Robert J. Kreitman et al.
BLOOD (2018)
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Robert J. Kreitman et al.
LEUKEMIA (2018)
Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience
Evgeniya A. Angelova et al.
MODERN PATHOLOGY (2018)
MRD Testing in Multiple Myeloma: From a Surrogate Marker of Clinical Outcomes to an Every-Day Clinical Tool
Ola Landgren
SEMINARS IN HEMATOLOGY (2018)
Evaluating measurable residual disease in acute myeloid leukemia
Farhad Ravandi et al.
BLOOD ADVANCES (2018)
Is there a role for minimal residual disease monitoring in the management of patients with hairy-cell leukaemia?
Valentin Ortiz-Maldonado et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
Michael R. Grever et al.
BLOOD (2017)
Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation
Monika Brueggemann et al.
BLOOD ADVANCES (2017)
Eliminating minimal residual disease as a therapeutic end point: working toward cure for patients with CLL
Philip A. Thompson et al.
BLOOD (2016)
Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial
Dai Chihara et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
2016 US Lymphoid Malignancy Statistics by World Health Organization Subtypes
Lauren R. Teras et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research
Zhongwu Lai et al.
NUCLEIC ACIDS RESEARCH (2016)
The Ensembl Variant Effect Predictor
William McLaren et al.
GENOME BIOLOGY (2016)
Hairy cell leukaemia-variant: Disease features and treatment
Estella Matutes et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2015)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series
Joshua D. Rosenberg et al.
BLOOD (2014)
FLAGS, frequently mutated genes in public exomes
Casper Shyr et al.
BMC MEDICAL GENOMICS (2014)
Cladribine with Immediate Rituximab for the Treatment of Patients with Variant Hairy Cell Leukemia
Robert J. Kreitman et al.
CLINICAL CANCER RESEARCH (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation
Liqiang Xi et al.
BLOOD (2012)
Using Drosophila melanogaster as a Model for Genotoxic Chemical Mutational Studies with a New Program, SnpSift
Pablo Cingolani et al.
Frontiers in Genetics (2012)
Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia
Farhad Ravandi et al.
BLOOD (2011)
Hairy-cell leukemia variant: Recent view on diagnosis, biology and treatment
Tadeusz Robak
CANCER TREATMENT REVIEWS (2011)
High-resolution genomic profiling in hairy cell leukemia-variant compared with typical hairy cell leukemia
S. L. Hockley et al.
LEUKEMIA (2011)
2-Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland
T. Robak et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy
Evgeny Arons et al.
BLOOD (2009)
Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis
Monica Else et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Phase II clinical study of cladribine in the treatment of hairy cell leukemia
T Machii et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
Minimal residual disease detection in hairy cell leukemia - Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene
JE Sausville et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
The natural history and clinico-pathological features of the variant form of hairy cell leukemia
E Matutes et al.
LEUKEMIA (2001)
分享论文
